NVO · Novo Nordisk A S · Webcasts, Transcripts & Audio
$41.63
+0.98 (+2.41%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$183.52B
Shares
4.41B
Volume · Nov 13
11.71M
Avg daily vol (3M)
12.34M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Novo Nordisk A S Webcasts
Earnings calls, investor updates, investor days and conferences for Novo Nordisk A S (NVO), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Earnings call
FY26 · Q4
2027-02-03
Novo Nordisk A S (NVO) Q4 2026 Earnings Call
Scheduled
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY26 · Q3
2026-11-04
Novo Nordisk A S (NVO) Q3 2026 Earnings Call Transcript
Confident tone
Financial performance and guidance
Oral GLP-1 launches
Pipeline and clinical milestones
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q2
2026-08-05
Novo Nordisk A S (NVO) Q2 2026 Earnings Call Transcript
Positive tone
Wegovy pill (WagoviPill/VigoviPill) launch and uptake
U.S. pricing pressure and channel mix
International operations and Wegovy pill ex-U.S. rollout
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2026-05-06
Novo Nordisk A S (NVO) Q1 2026 Earnings Call Transcript
Positive tone
2026 financial guidance and operating profit
Cost transformation, headcount and SG&A discipline
Intellectual property defense and loss of exclusivity
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Annual General Meeting
Investor event
2026-03-26
Novo Nordisk A S (NVO) March 26, 2026 Annual General Meeting
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q4
2025-12-31
Date not confirmed
Novo Nordisk A S (NVO) Q4 2025 Earnings Call Transcript
Positive tone
Wegovy pill launch
Obesity care growth
Pipeline readouts and approvals
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-09-30
Date not confirmed
Novo Nordisk A S (NVO) Q3 2025 Earnings Call Transcript
Balanced tone
Strategic focus on diabetes and obesity
GLP-1 franchise performance (Ozempic, Wegovy, Rybelsus)
Business development and M&A (Akero, Metsera)
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-06-30
Date not confirmed
Novo Nordisk A S (NVO) Q2 2025 Earnings Call Transcript
Cautious tone
Obesity care / Wegovy
Pipeline and R&D
GLP-1 diabetes / Ozempic
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-03-31
Date not confirmed
Novo Nordisk A S (NVO) Q1 2025 Earnings Call Transcript
Positive tone
GLP-1 volume leadership and patient growth
Wegovy U.S. obesity growth
Compounding impact and guidance cut
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q3
2024-09-30
Date not confirmed
Novo Nordisk A S (NVO) Q3 2024 Earnings Call Transcript
Confident tone
GLP-1 scaling and patient reach
Pipeline and R&D readouts
Obesity care growth
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-06-30
Date not confirmed
Novo Nordisk A S (NVO) Q2 2024 Earnings Call Transcript
Confident tone
GLP-1 franchise (Ozempic, Wegovy, Rybelsus)
Obesity Care and Wegovy supply
Sustainability and patients reached
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-03-31
Date not confirmed
Novo Nordisk A S (NVO) Q1 2024 Earnings Call Transcript
Confident tone
Obesity supply expansion (Wegovy)
R&D pipeline and readouts
GLP-1 sales momentum
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
Date not confirmed
Novo Nordisk A S (NVO) Q4 2023 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-09-30
Date not confirmed
Novo Nordisk A S (NVO) Q3 2023 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-06-30
Date not confirmed
Novo Nordisk A S (NVO) Q2 2023 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-03-31
Date not confirmed
Novo Nordisk A S (NVO) Q1 2023 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2022-12-31
Date not confirmed
Novo Nordisk A S (NVO) Q4 2022 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-09-30
Date not confirmed
Novo Nordisk A S (NVO) Q3 2022 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-06-30
Date not confirmed
Novo Nordisk A S (NVO) Q2 2022 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-03-31
Date not confirmed
Novo Nordisk A S (NVO) Q1 2022 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2021-12-31
Date not confirmed
Novo Nordisk A S (NVO) Q4 2021 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-09-30
Date not confirmed
Novo Nordisk A S (NVO) Q3 2021 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-06-30
Date not confirmed
Novo Nordisk A S (NVO) Q2 2021 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-03-31
Date not confirmed
Novo Nordisk A S (NVO) Q1 2021 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2020-12-31
Date not confirmed
Novo Nordisk A S (NVO) Q4 2020 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-09-30
Date not confirmed
Novo Nordisk A S (NVO) Q3 2020 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-06-30
Date not confirmed
Novo Nordisk A S (NVO) Q2 2020 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-03-31
Date not confirmed
Novo Nordisk A S (NVO) Q1 2020 Earnings Call Transcript
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Showing 1–28 of 28 webcasts
Key facts
CIK
353278
CUSIP
670100205
13F (30d)
960 filings
885 filers
Visit website
Investor relations